Paper46775
Prophylaxis of varicella in children with neoplastic disease: comparative results with zoster immune plasma and gamma globulin.
Geiser CF and 4 others. Cancer, 1975. Cited by 54 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Prophylaxis of varicella in children with neoplastic disease: comparative results with zoster immune plasma and gamma globulin. Papers, record 46775. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/46775
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Prophylaxis of varicella in children with neoplastic disease: comparative results with zoster immune plasma and gamma globulin.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Chickenpox | Major topic |
| Herpesvirus 3, Human | Major topic |
| Immunization, Passive | Major topic |
| Neoplasms | Major topic |
| gamma-Globulins | Major topic |
| Antineoplastic Agents | |
| Child | |
| Child, Preschool | |
| Encephalitis | |
| Humans | |
| Infant | |
| Leukemia | |
| Pneumonia |
Source PubMed
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 54 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 33430796 | Varicella zoster immune globulin (human) (VARIZIG) in immunocompromised patients: a subgroup analysis for safety and outcomes from a large, expanded-access program. | BMC Infect Dis | 2021 | https://conductscience.org/library/papers/33430796 | PubMed |
| 31269033 | Varicella zoster immune globulin (VARIZIG) administration up to 10 days after varicella exposure in pregnant women, immunocompromised participants, and infants: Varicella outcomes and safety results from a large, open-label, expanded-access program. | PLoS One | 2019 | https://conductscience.org/library/papers/31269033 | PubMed |
| 19043458 | Management of HSV, VZV and EBV infections in patients with hematological malignancies and after SCT: guidelines from the Second European Conference on Infections in Leukemia. | Bone Marrow Transplant | 2009 | https://conductscience.org/library/papers/19043458 | PubMed |
| 6988023 | [Therapeutic use of immunoglobulins in children (author's transl)]. | Blut | 1980 | https://conductscience.org/library/papers/6988023 | PubMed |
| 6779954 | Clinical pharmacology: plasma protein binding of drugs. | Br Med J (Clin Res Ed) | 1981 | https://conductscience.org/library/papers/6779954 | PubMed |
| 466591 | Clinical use of blood, blood components and blood products. | Can Med Assoc J | 1979 | https://conductscience.org/library/papers/466591 | PubMed |
| 442627 | Nosocomial varicella. Part II: suggested guidelines for management. | West J Med | 1979 | https://conductscience.org/library/papers/442627 | PubMed |
| 425501 | Nosocomial varicella. Part I: outbreak in oncology patients at a children's hospital. | West J Med | 1979 | https://conductscience.org/library/papers/425501 | PubMed |
| 203604 | Quantitation of antibodies to varicella-zoster virus by immune adherence hemagglutination. | J Clin Microbiol | 1978 | https://conductscience.org/library/papers/203604 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/46775
GET https://conductscience.org/api/papers/v1/46775/authors